AT323187B - Verfahren zur herstellung von neuen 5-sulfamylbenzoesäurederivaten und deren amiden, niedere alkylester und salzen - Google Patents

Verfahren zur herstellung von neuen 5-sulfamylbenzoesäurederivaten und deren amiden, niedere alkylester und salzen

Info

Publication number
AT323187B
AT323187B AT793171A AT793171A AT323187B AT 323187 B AT323187 B AT 323187B AT 793171 A AT793171 A AT 793171A AT 793171 A AT793171 A AT 793171A AT 323187 B AT323187 B AT 323187B
Authority
AT
Austria
Prior art keywords
amides
salt
preparation
new
acid derivatives
Prior art date
Application number
AT793171A
Other languages
German (de)
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to AT1025773A priority Critical patent/AT329072B/de
Application granted granted Critical
Publication of AT323187B publication Critical patent/AT323187B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT793171A 1970-09-14 1971-09-13 Verfahren zur herstellung von neuen 5-sulfamylbenzoesäurederivaten und deren amiden, niedere alkylester und salzen AT323187B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT1025773A AT329072B (de) 1970-09-14 1971-09-13 Verfahren zur herstellung von neuen 5-sulfamyl-benzoesaurederivaten und deren amiden, niederen alkylestern und salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7215670A 1970-09-14 1970-09-14

Publications (1)

Publication Number Publication Date
AT323187B true AT323187B (de) 1975-06-25

Family

ID=22105942

Family Applications (1)

Application Number Title Priority Date Filing Date
AT793171A AT323187B (de) 1970-09-14 1971-09-13 Verfahren zur herstellung von neuen 5-sulfamylbenzoesäurederivaten und deren amiden, niedere alkylester und salzen

Country Status (14)

Country Link
JP (1) JPS5512422B1 (nl)
AT (1) AT323187B (nl)
AU (1) AU468590B2 (nl)
BE (1) BE772381A (nl)
CA (1) CA983489A (nl)
CH (2) CH552575A (nl)
ES (2) ES394830A1 (nl)
FR (1) FR2106514B1 (nl)
GB (1) GB1353357A (nl)
KE (1) KE2573A (nl)
MY (1) MY7500253A (nl)
NL (1) NL173400C (nl)
SE (1) SE401673B (nl)
ZA (1) ZA715851B (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929803A (en) * 1974-05-28 1975-12-30 Pfizer Aryl carboxylic acids
WO1983000013A1 (en) * 1980-11-10 1983-01-06 Mochida Pharm Co Ltd Medicinal composition having an antiviral effect
SE8203877L (sv) * 1981-06-22 1982-12-23 Hodogaya Chemical Co Ltd Aminosulfonylbensoesyraderivat
EP0132540A1 (en) * 1981-06-22 1985-02-13 Mochida Pharmaceutical Co., Ltd. Antiviral compositions
JPS58192863A (ja) * 1982-05-06 1983-11-10 Hodogaya Chem Co Ltd 新規アミノスルホニル安息香酸エステル誘導体
JPS6323210U (nl) * 1986-07-31 1988-02-16
DE3732374A1 (de) * 1987-09-25 1989-04-06 Basf Lacke & Farben Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel
JPH0248510U (nl) * 1988-09-28 1990-04-04
EP1218341B1 (de) * 1999-09-01 2005-08-24 Aventis Pharma Deutschland GmbH Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19941559A1 (de) * 1999-09-01 2001-03-15 Aventis Pharma Gmbh Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH433378A (de) * 1962-03-09 1967-04-15 Ciba Geigy Verfahren zur Herstellung neuer Anthranilsäurederivate
FR1525352A (fr) * 1967-04-06 1968-05-17 Ile De France Procédé de préparation des acides 2-alcoxy-5-sulfamido-benzoïques

Also Published As

Publication number Publication date
CH569706A5 (nl) 1975-11-28
SE401673B (sv) 1978-05-22
ES421977A1 (es) 1976-05-01
BE772381A (fr) 1972-03-09
GB1353357A (en) 1974-05-15
MY7500253A (en) 1975-12-31
ZA715851B (en) 1972-05-31
AU468590B2 (en) 1976-01-15
DE2145686B2 (de) 1977-07-07
FR2106514A1 (nl) 1972-05-05
KE2573A (en) 1975-10-31
NL173400B (nl) 1983-08-16
NL173400C (nl) 1984-01-16
FR2106514B1 (nl) 1975-08-01
CA983489A (en) 1976-02-10
NL7112598A (nl) 1972-03-16
AU3308471A (en) 1973-03-08
JPS5512422B1 (nl) 1980-04-02
ES394830A1 (es) 1974-12-01
DE2145686A1 (de) 1972-04-20
CH552575A (fr) 1974-08-15

Similar Documents

Publication Publication Date Title
ATA266376A (de) Verfahren zur herstellung von neuen substituierten 3-aminoalkylamino-2-hydroxy-1-phenoxypropanen und von deren saureadditionssalzen
AT330150B (de) Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
AT310174B (de) Verfahren zur Herstellung von neuen Azepin-Derivaten und deren Säureadditionssalzen
AT321276B (de) Verfahren zur Herstellung von neuen substituierten 3-Phenoxy-aminopropan-2-olen und deren Säureadditionssalzen
AT323187B (de) Verfahren zur herstellung von neuen 5-sulfamylbenzoesäurederivaten und deren amiden, niedere alkylester und salzen
AT310764B (de) Verfahren zur Herstellung von neuen Azepin-Derivaten und deren Säureadditionssalzen
AT293419B (de) Verfahren zur Herstellung von neuen 1-Carbamyl-3-phenylpyrrolidinen und deren Säureadditionssalzen
AT308123B (de) Verfahren zur Herstellung von neuen Thienobenzothiazepinderivaten und von deren Säureadditionssalzen
AT321265B (de) Verfahren zur Herstellung von neuen Benzobicycloalkanaminen und deren Säureadditionssalzen
AT317901B (de) Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten und deren Säureadditionssalzen
AT298495B (de) Verfahren zur Herstellung von neuen Diallylaminoalkanoylamiden und von deren Säureadditionssalzen
AT310156B (de) Verfahren zur Herstellung von neuen Thienyl-imidazolyl-fettsäurederivaten und deren Salzen
AT302994B (de) Verfahren zur Herstellung von neuen N-Aminoäthoxyacetyl-aminoadamantanen und deren Säureadditionssalzen
AT320611B (de) Verfahren zur Herstellung von neuen substituierten Phenylformamidinen und deren Säureadditionssalzen
AT310143B (de) Verfahren zur Herstellung von neuen 1-Acylaminoalkylphenoxy-2- -hydroxy-3-alkylaminopropanen und von deren Säureadditionssalzen
AT313874B (de) Verfahren zur Herstellung von neuen 2-Hydroxy- oder 2,3-Dihydroxy-5-alkoxycarbonyl-benzyloxyaminen und deren Säureadditionssalzen
AT303034B (de) Verfahren zur Herstellung von neuen Imidazolinderivaten und von deren Säureadditionssalzen
AT305250B (de) Verfahren zur Herstellung von neuen 1-Hydroxyphenyl-1-hydroxy-2-(3-aryl-3-hydroxypropyl)-aminoäthanen und von deren Säureadditionssalzen
AT331778B (de) Verfahren zur herstellung von neuen 2,2,3-trimethyl-7-aminonorbornanen und deren saureadditionssalzen
AT329072B (de) Verfahren zur herstellung von neuen 5-sulfamyl-benzoesaurederivaten und deren amiden, niederen alkylestern und salzen
AT318556B (de) Verfahren zur Herstellung von neuen 2-Aminobornanen und von deren Säureadditionssalzen
AT302314B (de) Verfahren zur Herstellung von neuen 7-Acyl-1,2,4,5-tetrahydro-(3H)-3-benzazepinen und deren Säureadditionssalzen
AT308720B (de) Verfahren zur Herstellung von neuen substituierten N-Phenylthioalkyl-phenylalkanolaminen und von deren Säureadditionssalzen
AT310183B (de) Verfahren zur Herstellung von neuen Pyridazinderivaten und von deren Säureadditionssalzen
AT313911B (de) Verfahren zur herstellung von neuen pyridochinolinderivaten und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee